𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal anti-A antibody removal by synthetic A antigen immobilized on specific antibody filters

✍ Scribed by Shalini Gautam; Elena Y. Korchagina; Nicolai V. Bovin; William J. Federspiel

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
191 KB
Volume
99
Category
Article
ISSN
0006-3592

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Removal of blood group anti‐A and anti‐B antibodies can prevent hyperacute organ rejection in ABO‐incompatible transplantation. We are developing an extracorporeal‐specific antibody filter (SAF) as an immunoadsorption device for direct removal of ABO blood group antibodies from whole blood, without the need for plasma separation and plasma exchange. A hollow fiber‐based small scale SAF (mini‐SAF) device was fabricated and synthetic A antigen, Atrisaccharide (Atri) conjugated to activated polyacrylic acid, was immobilized on the fiber lumen surface. Monoclonal antibody anti‐A IgM were specifically removed up to 70% of initial antibodies using mini‐SAF device. The monoclonal anti‐A capture experiments on mini‐SAF indicated that antibody removal relative to the initial concentration is independent of inlet concentration in the beginning; however, as the surface starts saturating with bound antibodies, removal becomes dependent on inlet concentration. No significant effect of flow rate on removal rate was observed. The radial diffusion and axial convection‐based mathematical model developed for unsteady state antibody removal was in good agreement with the experimental data and showed that the antibody removal rate can be maximized by increasing the antibody‐binding capacity of the SAF. Biotechnol. Bioeng. 2008;99: 876–883. © 2007 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Specific antibody filter (SAF) binding c
Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies
✍ Shalini Gautam; Elena Y. Korchagina; Nicolai V. Bovin; William J. Federspiel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

## Abstract Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The de

Human melanoma-specific oncofetal antige
Human melanoma-specific oncofetal antigen defined by a mouse monoclonal antibody
✍ Dr. Shuen-Kuei Liao; Bryan J. Clarke; Mohammed Khosravi; Pak C. Kwong; Anne Bric 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 794 KB

## Abstract 140.240, an IgG2a mouse monoclonal antibody raised against a cultured human melanoma cell line, was highly specific for melanoma cells as determined by direct and absorption analyses in a mixed hemadsorption assay. Supernatants of doubly cloned hybridomas producing antibody 140.240 reac

Mimicry of a carcinoembryonic antigen ep
Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody
✍ Michele J. Losman; Kristine E. Novick; David M. Goldenberg; Marc Monestier 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 730 KB

## Abstract Anti‐idiotype antibodies (Ab2) that immunologically mimic tumor antigens are auspicious agents for the active immunization of cancer patients. We have developed W12, a rat monoclonal IgG~1~ Ab2 to MN ‐14, a murine anti‐carcinoembryonic antigen (CEA) monoclonal antibody. W12 is specific

A new cancer-associated antigen defined
A new cancer-associated antigen defined by a monoclonal antibody against a synthetic carbohydrate chain
✍ Yoshito Yamashita; Yong Suk Chung; Tetsuji Sawada; Yasuyuki Kondo; Koji Hirayama 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 985 KB

## Abstract Carbohydrate antigens can be designed by referring to previously defined carbohydrate structures. We have generated a novel monoclonal antibody (MAb) (Flα‐75) against an artificially designed antigen (Flα), using organic‐synthetic chemistry methods and hybridoma technology. Flα (GalβI →